ImmuCell Corp
NASDAQ:ICCC
ImmuCell Corp
Other Current Liabilities
ImmuCell Corp
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ImmuCell Corp
NASDAQ:ICCC
|
Other Current Liabilities
$332.7k
|
CAGR 3-Years
33%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is ImmuCell Corp's Other Current Liabilities?
Other Current Liabilities
332.7k
USD
Based on the financial report for Mar 31, 2024, ImmuCell Corp's Other Current Liabilities amounts to 332.7k USD.
What is ImmuCell Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
12%
Over the last year, the Other Current Liabilities growth was 138%. The average annual Other Current Liabilities growth rates for ImmuCell Corp have been 33% over the past three years , 12% over the past five years .